About Index Trending news
Analyze
Pricing
Abeona Therapeutics

Abeona Therapeutics

Work at Abeona Therapeutics? Add yourself to this profile

Abeona Therapeutics

Abeona is developing therapies for children with rare lysosomal diseases for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Complexa Complexa Clearside BioMedical, Inc. Clearside BioMedical, Inc. Mersana Therapeutics Mersana Therapeutics Hengrui Therapeutics, Inc. Hengrui Therapeutics, Inc. Allinaire Therapeutics Allinaire Therapeutics Vividion Therapeutics Vividion Therapeutics Atterx Biotherapeutics Atterx Biotherapeutics ArGEN-X ArGEN-X CoDa Therapeutics, Inc. CoDa Therapeutics, Inc. 3-V Biosciences 3-V Biosciences

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Venture capital
$8,500,000
George Soros
Venture capital
$3,600,000
Employees

Unknown size

Locations
HQ
United States
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Abeona Therapeutics makes some noise.